U.S. markets open in 1 hour 5 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
9.48-0.36 (-3.66%)
At close: 4:00PM EST

9.68 +0.20 (2.11%)
Pre-Market: 8:25AM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 2/20/2021
Current
9/30/20206/30/20203/31/202012/31/2019
Market Cap (intraday) 5
3.69B96.43M46.91M17.18M42.50M
Enterprise Value 3
3.69B94.95M55.73M19.95M54.01M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
133.713.191.160.671.15
Price/Book (mrq)
251.3416.52N/A4.75N/A
Enterprise Value/Revenue 3
504.7443.2447.1517.5619.36
Enterprise Value/EBITDA 6
-110.28-9.63-7.73-2.11-8.05

Premium access required.

Learn more

Trading Information

Stock Price History

Beta (5Y Monthly) 2.37
52-Week Change 3769.72%
S&P500 52-Week Change 323.65%
52 Week High 315.69
52 Week Low 30.25
50-Day Moving Average 310.73
200-Day Moving Average 33.36

Share Statistics

Avg Vol (3 month) 389.54M
Avg Vol (10 day) 327.81M
Shares Outstanding 5271.83M
Float 151.94M
% Held by Insiders 10.06%
% Held by Institutions 15.64%
Shares Short (Feb 11, 2021) 419.05M
Short Ratio (Feb 11, 2021) 40.24
Short % of Float (Feb 11, 2021) 47.01%
Short % of Shares Outstanding (Feb 11, 2021) 47.01%
Shares Short (prior month Jan 14, 2021) 425.47M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-453.08%

Management Effectiveness

Return on Assets (ttm)-68.24%
Return on Equity (ttm)-1,021.64%

Income Statement

Revenue (ttm)7.3M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)-33.70%
Gross Profit (ttm)3.36M
EBITDA -31.86M
Net Income Avi to Common (ttm)-37.28M
Diluted EPS (ttm)-0.52
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.87M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)16.01M
Total Debt/Equity (mrq)109.12
Current Ratio (mrq)1.18
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-35.59M
Levered Free Cash Flow (ttm)-16.34M